PENELOPE: TAR-200 Shows Deeper Tissue Penetration vs Standard Intravesical Therapy
8:50
The SunRISe Trials and TAR-200: Bladder-Sparing Therapies for NMIBC
26:56
Bladder Cancer Immunotherapy: Building on a history of immune response
6:13
Molecular Imaging Breakthroughs in Kidney Cancer: Dr. Brian Shuch at SUO 2024
8:08
Subcutaneous Nivolumab for RCC: CheckMate 67T Practice-Changing Results
58:06
Axiom ASH Townhall: Choosing Between Key Modalities in Heme-Onc
15:35
longevidad 2024
8:15
Novel intravesical chemotherapy delivery system in NMIBC
20:15